Mobile ordering technology for hospital employees just got a major tech upgrade. Photo courtesy of Rivalry Tech

Houston-based Rivalry Tech announced that it has partnered up with Canadian RoboEatz to bring hospital employees on-demand meals 24/7.

RoboEatz is known for its autonomous robotic kitchen system, which prepares high-quality dishes efficiently and consistently for health care organizations, businesses, higher education institutions and quick-service restaurants.

Rivalry Tech will couple RoboEatz's system with its user interface, known as myEATZ, that's currently in use at several Houston Methodist Hospitals, the TMC Innovation Factory, and in resorts, hospitals, office buildings, and more, according to the company's website.

"At Rivalry Tech, we're dedicated to pushing our boundaries into cutting-edge technologies with innovative partners like RoboEatz," Aaron Knape, CEO of Rivalry Tech, says in a statement. "Partnering with RoboEatz allows us to take this commitment a step further by providing an interface that gives users complete control over their dining choices and preferences."

Rivalry Tech originally founded myEATZ as an in-stadium ordering app in 2018, then known as sEATz. The company rebranded and introduced myEATz in 2022 and launched a new app about a year ago.

The company raised $3.5 million in funding to expand into the health care space in 2022 and initially rolled out at Houston Methodist The Woodlands Hospital, Houston Methodist West Hospital, Houston Methodist Clear Lake Hospital, Houston Methodist Continuing Care Hospital, and Houston Methodist Willowbrook Hospital last spring. According to Rivalry, its partner Aramark Healthcare+ has been important to the expansion of their technology within the health care sector.

"We believe this partnership marks a pivotal moment in the evolution of dining technology," Janis Poruks, CTO and Co-Founder of RoboEatz, said in a statement. "By integrating Rivalry Tech's user interface with our automated robotic kitchen, we're transforming dining into an interactive and personalized experience. Our goal is to redefine convenience and quality in dining while reducing the need for full-time employees."

MyEATZ, then sEATz, was part of Softeq Development’s accelerator in 2022. Click here to see the latest Houston tech companies to join.
More Houston-area hospital workers now have access to this Houston startup's mobile ordering platform. Image courtesy of Rivalry Tech

Mobile ordering tech company expands to 5 Houston hospitals

hi, tech

More Houston hospital workers now have access to on-demand mobile ordering thanks to a Houston startup.

Houston-based Rivalry Tech has rolled out its its mobile ordering platform, myEATz, into five of Houston Methodist's hospital cafes. The hospital employees can now order food and beverages from the myEATz app or web platform.

The platform is now available at: Houston Methodist The Woodlands Hospital, Houston Methodist West Hospital, Houston Methodist Clear Lake Hospital, Houston Methodist Continuing Care Hospital, and Houston Methodist Willowbrook Hospital.

"Employee wellness is especially important in healthcare as worker shortages, combined with fatigue, continue to be a concern," says Aaron Knape, CEO and co-founder of Rivalry Tech, in a news release. "MyEATz offers more than just access to onsite food and beverage options, it encourages employees to utilize their meal breaks to recharge and make the most of their break."

The expansion aligns with Rivalry's partnership with Aramark Healthcare+, which operates all of the dining operations at Houston Methodist.

“We are thrilled to expand our partnership with Rivalry Tech to bring mobile ordering to five additional Aramark Healthcare+ Houston Methodist locations," says Dave Hanson, vice president of operations at Aramark Healthcare+, in the release. "Our continued investment in technology is a testament to our commitment to providing exceptional service and convenience to our healthcare caregivers. With Rivalry Tech's myEATz platform and our operational expertise, we are confident in our ability to enhance the overall dining experience for our guests.”

Founded in 2018 as sEATz, an in-stadium ordering app, Rivalry Tech rebranded and introduced the myEATz concept last year. Since then, the company rolled out its new app and raised $3.5 million in funding to expand its technology into the health care hospitality space.

A Houston startup is making mobile food ordering a whole lot easier within health care facilities. Photo by Jonas Leupe on Unsplash

Houston tech company launches app to upgrade mobile ordering

download now

A Houston tech company has launched its mobile ordering app, the company announced last week.

Rivalry Tech, which created sEATz, an in-seat food delivery platform for sports and entertainment venues, has launched myEATZ in the App Store and Google Play. The platform is designed for facilities with 24/7/365 dining needs, and the app's initial focus is on the health care industry.

Health care employees work long shifts and have to optimize their break time. With the myEATZ app, these workers can order ahead and skip the line at nearby eateries. For Rivalry Tech's co-founder and CEO, Aaron Knape, being able to provide this tool to health care workers is a personal win for him.

“Being married to a nurse, and living next door to the largest medical center in the world, I’ve seen the challenges faced by healthcare workers the past few years," he says in a news release. "To offset long hours and short breaks, the myEATz platform can truly give time back to healthcare workers by letting them skip the line.”

Outside of health care, myEATz has also identified opportunities within the hospitality industry. Last year, myEATz launched at Margaritaville Lake Conroe to allow guests to mobile order food and beverage directly to their pool chair. The expansion is in its second phase with plans to rollout into other hotels.

Originally founded as sEATz in 2018 by Knape, Marshall Law, and Craig Ceccanti, Rivalry Tech raised $3.5 million in November. The round was led by Houston-based Sightcast, with participation from Houston-based Softeq Venture Studio, Rice University’s Valhalla Investment Group, and more.

The myEATz app is available now. Image courtesy of Rivalry Tech

This week's roundup of Houston innovators includes Betsy Furler of For All Abilities, Marshall Law and Aaron Knape of Rivalry Tech, and 11 Houston Innovation Awards winners. Photos courtesy

3+ Houston innovators to know this week

who's who

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to over a dozen local innovators across industries — from cognitive tech to mobile ordering — recently making headlines in Houston innovation. That's right it's a special edition of this Monday feature. Scroll to see the 11 honorees from the Houston Innovation Awards Gala.

Betsy Furler, co-founder and CEO of For All Abilities

Betsy Furler, co-founder and CEO of For All Abilities, joins this week's Houston Innovators Podcast. Photo courtesy of For All Abilities

The fact that people's cognitive abilities differ widely is not exactly new information, but with new technologies and information about the subject, communities are able to learn better and more efficient ways of coping with neurodiversity — especially in the workplace. Betsy Furler, founder and CEO of Houston-based For All Abilities, is working on a unique approach to these challenges.

After its initial assessment, For All Abilities, which operates as a subscription software model for businesses, provides employees with curated low or no-cost apps and efficiency tools. While her work is mission-driven, Furler says on the show she was very intentional on starting her organization as a for-profit tech startup.

"It really makes sense from a business perspective to support your employees this way," she says. Click here to read more.

Marshall Law and Aaron Knape of Rivalry Technologies

Rivalry Tech's co-founders — Marshall Law and Aaron Knape — share news of the company's latest round of investment. Photo courtesy of Rivalry Tech

Rivalry Tech, originally founded as sEATz and tackling mobile ordering in sports venues, has raised $3.5 million following expanding with a new product, myEATz, that targets the health care, leisure, and business industries. The round was led by Houston-based Sightcast, with participation from Houston-based Softeq Venture Studio, Rice University’s Valhalla Investment Group, and more.

Co-Founders Aaron Knape, Marshall Law, and Craig Ceccanti launched the company in 2018. The idea came to Law after he missed catching a home run ball in the 2017 World Series because he was stuck in a long line waiting for concessions.

“We have built an amazing mobile ordering platform over the last four years for some of the best teams in professional and collegiate sports. It is exciting to see our success in sports and entertainment translate into opportunities in other industries. People want the best mobile ordering experience no matter where they are. That is exactly what we provide,” says Law. Click here to read more.

Meet the startup founders, mentors, investors, and other innovation leaders honored at the Houston Innovation Awards Gala

The 2022 Houston Innovation Awards revealed its big winners across 11 categories. Photos courtesy

Last Wednesday, InnovationMap and Houston Exponential announced the winners of the 2022 Houston Innovation Awards Gala. Eleven founders, mentors, investors, and more took home wins. Click here to read more.

Rivalry Tech's co-founders — Marshall Law and Aaron Knape — share news of the company's latest round of investment. Photo courtesy of Rivalry Tech

Houston tech startup raises $3.5M following industry expansion

money moves

A Houston-based company that optimizes mobile ordering for large venues has closed its latest round of funding.

Rivalry Tech, originally founded as sEATz and tackling mobile ordering in sports venues, has raised $3.5 million following expanding with a new product, myEATz, that targets the health care, leisure, and business industries. The round was led by Houston-based Sightcast, with participation from Houston-based Softeq Venture Studio, Rice University’s Valhalla Investment Group, and more.

“Sightcast Capital Partners looks to invest in strong, founder-led companies that bring a forward-thinking solution to everyday problems," says Neal Simpson, managing partner of Sightcast Capital Partners, in a news release. "In Rivalry Tech, we saw a team that recognized an opportunity to streamline the way in which food and beverage transactions occur in the healthcare, leisure, sports, and entertainment markets. Their two-sided approach of using technology as a tool to increase vendor profitability and also positively influence consumer experience is what immediately attracted us to this opportunity."

The company also recently announced it joined Softeq Venture Studio's latest accelerator cohort that was unveiled last month.

“As we begin scaling our customer base, Softeq was the perfect choice as both an investment and development partner. With their focus on innovation combined with their extensive experience in enterprise software and hardware, we believe they can strategically elevate us to the next level,” says Aaron Knape, CEO and co-founder of Rivalry Tech.

Knape and his co-founders — Marshall Law and Craig Ceccanti — launched the company in 2018. The idea came to Law after he missed catching a home run ball in the 2017 World Series because he was stuck in a long line waiting for concessions.

“We have built an amazing mobile ordering platform over the last four years for some of the best teams in professional and collegiate sports. It is exciting to see our success in sports and entertainment translate into opportunities in other industries. People want the best mobile ordering experience no matter where they are. That is exactly what we provide,” says Law.

This growing mobile ordering startup has rebranded to represent its growth. Photo courtesy of sEATz

Growing Houston sportstech company rebrands following platform expansion

the rivalry is on

The Houston startup that enabled in-seat food and beverage ordering at stadiums has grown over the past few years — and the company has entered into its new era with a rebrand.

Houston-based sEATz expanded this year to evolve its technology to enable optimized mobile ordering within hospitals. Launching that new platform, called myEATz, led to a need for a defined parent company to account for the growing company. Rivalry Technology will be run by the same sEATz and myEATz team.

“I always knew that sEATz would grow into something special," says Rivalry Tech CEO and Co-Founder Aaron Knape in a news release. "As we continue to expand and grow, our brand has also grown with it. With sEATz holding sway over Sports and Entertainment, and the myEATz platform making rapid inroads into healthcare, business dining and leisure, the Rivalry Tech branding will help pull it all together.”

The rebrand comes with a new logo, website, and social media accounts. Rivalry's chief of staff, Megan Fier, designed the new logo with sEATz's original design and colors in mind.

“Knowing how recognized the sEATz brand has become, I needed to design the Rivalry Tech logo to compliment that," she says in the release. "The dual arrows pointing together represent our two platform brands. The orange sEATz half shows where we started while the navy blue myEATz shows where we are going.”

The new website also showcases both brands with information for those interested in both platforms.

“Prior to our rebrand, we had two separate websites presenting as two separate companies," Fier says. "I wanted our website to be our go-to place for both sEATz and myEATz, to show that cohesion and showcase the depth of our offerings as Rivalry Tech. The new Rivalry Tech website shares our products, tells our story, and gives site visitors a place to connect to our team all in one website. Afterall, we are more than just mobile ordering.”

The name reflects the three sEATz co-founders' alma maters: Knape graduated from Texas A&M University, Marshall Law from the University of Texas, and Craig Ceccanti from Louisiana State University.

“An Aggie, a Longhorn, and an LSU Tiger walked into a bar," Knape explains, "and it was the only name on which we could agree.“

Founded in 2018, the company has raised two seed rounds — one in 2019 and another amid the pandemic in 2020. Following that funding, Knape previously told InnovationMap that he's focused on the company's growth.

"I tell the team that we're kind of coming out of stealth mode — I know we're not in a true stealth mode, but we haven't spent a lot of money on sales and marketing," Knape says on the Houston Innovators Podcast. "Now it's time to start putting that emphasis on who we are, that we're here, and we're ready to take over."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.